abstract |
The present invention relates to RSK inhibitors capable of exhibiting one or more beneficial therapeutic effects. RSK inhibitors may be used in the prevention and/or treatment of viral infections. RSK inhibitors, alone or in combination with other antiviral inhibitor compounds, may exhibit one or more beneficial therapeutic effects in the treatment of viral diseases. |